PGE2 Production in Oral Cancer Cell Lines is COX-2-dependent
暂无分享,去创建一个
[1] T. Christoffersen,et al. A study of phosphorylated ERK1/2 and COX-2 in early stage (T1-T2) oral squamous cell carcinomas. , 2008, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[2] H. Kishimoto,et al. Prognostic significance of cyclooxygenase‐2 and DNA topoisomerase IIα expression in oral carcinoma , 2007 .
[3] B. Rubino,et al. The role of epithelial-mesenchymal transition in cancer pathology. , 2007, Pathology.
[4] Paula D. Bos,et al. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis , 2007, Nature.
[5] P. Weinreb,et al. Cyclooxygenase-2 Inhibition Suppresses αvβ6 Integrin–Dependent Oral Squamous Carcinoma Invasion , 2006 .
[6] S. Gallus,et al. Aspirin and cancer risk: an updated quantitative review to 2005 , 2006, Cancer Causes & Control.
[7] C. Haglund,et al. Cyclooxygenase-2 expression in squamous cell carcinoma of the oral cavity and pharynx: association to p53 and clinical outcome. , 2006, Oncology reports.
[8] P. Jakobsson,et al. Inhibition of prostaglandin E2 synthesis by SC‐560 is independent of cyclooxygenase 1 inhibition , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] S. Reddy,et al. A Phosphatidylinositol 3-Kinase-regulated Akt-Independent Signaling Promotes Cigarette Smoke-induced FRA-1 Expression* , 2006, Journal of Biological Chemistry.
[10] Sui-Po Zhang,et al. Cloning, Expression, and Functional Characterization of Human Cyclooxygenase-1 Splicing Variants: Evidence for Intron 1 Retention , 2005, Journal of Pharmacology and Experimental Therapeutics.
[11] P. Puolakkainen,et al. Intron 1 retaining cyclooxygenase 1 splice variant is induced by osmotic stress in human intestinal epithelial cells. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.
[12] Yuko Kino,et al. Prostaglandin E2 production in ovarian cancer cell lines is regulated by cyclooxygenase-1, not cyclooxygenase-2. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.
[13] Li Zhu,et al. Prostaglandin E2 Induces FOXP3 Gene Expression and T Regulatory Cell Function in Human CD4+ T Cells1 , 2005, The Journal of Immunology.
[14] S. Lippman,et al. Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] W. Isaacs,et al. Cyclooxygenases in cancer: progress and perspective. , 2004, Cancer letters.
[16] Ryuichi Hayashi,et al. Predictive Markers for Late Cervical Metastasis in Stage I and II Invasive Squamous Cell Carcinoma of the Oral Tongue , 2004, Clinical Cancer Research.
[17] D. Costea,et al. Crucial effects of fibroblasts and keratinocyte growth factor on morphogenesis of reconstituted human oral epithelium. , 2003, The Journal of investigative dermatology.
[18] Makoto Murakami,et al. Cellular Prostaglandin E2 Production by Membrane-bound Prostaglandin E Synthase-2 via Both Cyclooxygenases-1 and -2* , 2003, Journal of Biological Chemistry.
[19] D. Elder,et al. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[20] Donald E Ingber,et al. Cancer as a disease of epithelial-mesenchymal interactions and extracellular matrix regulation. , 2002, Differentiation; research in biological diversity.
[21] N. V. Chandrasekharan,et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[22] J. Shah,et al. Cyclooxygenase‐2: A novel molecular target for the prevention and treatment of head and neck cancer , 2002, Head & neck.
[23] T. Paavonen,et al. Expression of cyclo-oxygenase-2 in human tongue carcinoma and its precursor lesions , 2002, Virchows Archiv.
[24] P. Jakobsson,et al. Coordinate up- and down-regulation of glutathione-dependent prostaglandin E synthase and cyclooxygenase-2 in A549 cells. Inhibition by NS-398 and leukotriene C4. , 2000, European journal of biochemistry.
[25] Makoto Murakami,et al. Regulation of Prostaglandin E2 Biosynthesis by Inducible Membrane-associated Prostaglandin E2 Synthase That Acts in Concert with Cyclooxygenase-2* , 2000, The Journal of Biological Chemistry.
[26] Makoto Murakami,et al. Molecular Identification of Cytosolic Prostaglandin E2 Synthase That Is Functionally Coupled with Cyclooxygenase-1 in Immediate Prostaglandin E2Biosynthesis* , 2000, The Journal of Biological Chemistry.
[27] S. Laufer,et al. Development of an in-vitro test system for the evaluation of cyclooxygenase-2 inhibitors , 1999, Inflammation Research.
[28] J. Shah,et al. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. , 1999, Cancer research.
[29] C. Koboldt,et al. Pharmacological analysis of cyclooxygenase-1 in inflammation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[30] 柴田 昌美. Cyclo-oxygenase-1 and -2 expression in human oral mucosa, dysplasias and squamous cell carcinomas and their pathological significance , 2005 .
[31] J. Travers,et al. Aspirin use and reduced risk of fatal colon cancer. , 1992, The New England journal of medicine.